Cargando…
NS5ABP37 inhibits liver cancer by impeding lipogenesis and cholesterogenesis
The molecular mechanism underlying non‐alcoholic fatty liver disease progression to hepatocellular carcinoma (HCC) remains unknown. In this study, immunohistochemistry staining results showed that NS5ABP37 protein, which is in a state of lower expression in tumor tissues, decreased with increasing d...
Autores principales: | Feng, Shenghu, Han, Ming, Zhou, Li, Wang, Qi, Li, Zhongshu, Li, Yaru, Lu, Hongping, Liu, Ting, Ma, Yanhua, Liu, Shunai, Cheng, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5276832/ https://www.ncbi.nlm.nih.gov/pubmed/27862769 http://dx.doi.org/10.1111/cas.13117 |
Ejemplares similares
-
miR-185 Inhibits Fibrogenic Activation of Hepatic Stellate Cells and Prevents Liver Fibrosis
por: Zhou, Li, et al.
Publicado: (2017) -
Amoxillin- and pefloxacin-induced cholesterogenesis and phospholipidosis in rat tissues
por: Rotimi, Solomon O, et al.
Publicado: (2015) -
HCBP6 upregulates human SREBP1c expression by binding to C/EBPβ-binding site in the SREBP1c promoter
por: Yang, Xueliang, et al.
Publicado: (2018) -
Industrial Trans Fatty Acids Stimulate SREBP2‐Mediated Cholesterogenesis and Promote Non‐Alcoholic Fatty Liver Disease
por: Oteng, Antwi‐Boasiako, et al.
Publicado: (2019) -
NS5ATP9 Contributes to Inhibition of Cell Proliferation by Hepatitis C Virus (HCV) Nonstructural Protein 5A (NS5A) via MEK/Extracellular Signal Regulated Kinase (ERK) Pathway
por: Wang, Qi, et al.
Publicado: (2013)